Whole Breast Irradiation Versus Intraoperative Electron Radiation Therapy for Breast Conserving Therapy: A Large Mature Single Institution Matched-Pair Evaluation of True Local Relapse, Progression Free Survival, and Overall Survival

医学 累积发病率 放射治疗 乳腺癌 入射(几何) 术中放疗 分级(工程) 保乳手术 外科 内科学 肿瘤科 癌症 乳房切除术 队列 物理 土木工程 光学 工程类
作者
Fiorenza De Rose,Salvatore Mussari,Lucia Di Brina,Daniele Ravanelli,F. Ziglio,L. Menegotti,Antonella Ferro,A. Caldara,G Berlanda,Fabio Gasperetti,Elena Magri,Laura Bandera,P. Ferrazza,Sergio Fersino,Maria Andolina,A. Martignano,Anna Delana,Said Bou Selman,V. Vanoni
出处
期刊:International Journal of Radiation Oncology Biology Physics [Elsevier BV]
卷期号:116 (4): 757-769 被引量:6
标识
DOI:10.1016/j.ijrobp.2023.01.049
摘要

Comparative outcome data after intraoperative radiation therapy and whole breast irradiation (WBI) for breast cancer at >10 years median follow-up are rare. We present a mature, single-institution, matched-pair comparison reporting survival and relapse rates in patients treated with either modality.Complete data sets for 258 intraoperative electron radiation therapy (IOERT) patients treated between 2000 and 2010 were matched with 258 patients postoperatively treated with WBI by age/histology/tumor size, grading/lymph-node-status/hormone receptors/type of adjuvant therapy/surgical margins, and treatment date. Relapse at surgical intervention site was classified as true local recurrence (LR). All recurrences in the treated breast (any quadrant) were classified as ipsilateral recurrence (IR).Median follow-up was 157 months (12-251) for the IOERT group and 154 months (31-246) for the WBI group. Cumulative incidence of IR at 5, 10, and 15 years was 2.4%, 7.9%, and 12.7% for IOERT and 1.2%, 4.1%, and 5.0% for WBI (P = .02). Cumulative incidence of LR at 5, 10, and 15 years was 1.6%, 5.1%, and 8.3% for IOERT and 0.4%, 2.1%, and 2.5% for WBI (P = .02). No differences in overall survival, disease-free survival, second cancer incidence, or cardiac events were recorded in either treatment group. Outcome was better in the accelerated partial breast irradiation (APBI)-suitable group than in the APBI-unsuitable group (2009 criteria) (cumulative incidence of IR at 5, 10, and 15 years was 0% vs 7.3%, 6.1% vs 13.3%, and 7.3% vs 19.9% for IOERT and 0% vs 1.8%, 2.0% vs 3.9%, and 3.1% vs 3.9% for WBI) and in the revised APBI-suitable group than in the APBI-cautionary group (2017 criteria) (cumulative incidence of IR at 5, 10, and 15 years was 1.1% vs 6.4%, 6.2% vs 13.3%, and 7.8% vs 27.5% for IOERT and 1.7% vs 0%, 4.1% vs 4.4%, and 5.4% vs 4.4% for WBI).The IR and LR rate were higher after IOERT than after WBI for the American Society for Radiation Oncology suitable patient group, although without reaching statistical significance. Thus, IOERT could be an alternative to WBI upon stringent patient selection, but patients should be counseled carefully about the potential for increased IR rate with IOERT. Second cancer incidence and cardiac events did not differ between IOERT and WBI.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
nuuo完成签到,获得积分10
1秒前
鳗鱼鞋垫完成签到,获得积分10
2秒前
flyd发布了新的文献求助30
3秒前
lzh发布了新的文献求助10
4秒前
wuyisha发布了新的文献求助10
4秒前
盼盼发布了新的文献求助30
5秒前
平淡映易完成签到 ,获得积分10
6秒前
6秒前
科研通AI6.3的应助被ww采纳,获得10
6秒前
9秒前
薛南南发布了新的文献求助10
10秒前
坚强土豆完成签到,获得积分10
10秒前
11秒前
11秒前
小铭发布了新的文献求助10
12秒前
guojiyao完成签到,获得积分10
13秒前
14秒前
14秒前
临江jjjj发布了新的文献求助10
16秒前
怕黑的白筠完成签到,获得积分10
16秒前
17秒前
Frank发布了新的文献求助10
18秒前
18秒前
CodeCraft的应助被夏侯乌采纳,获得10
18秒前
19秒前
锦葵科的棉花完成签到,获得积分10
19秒前
JIU发布了新的文献求助10
20秒前
20秒前
芙蓉完成签到 ,获得积分10
21秒前
superpharm完成签到,获得积分10
21秒前
猜不猜不发布了新的文献求助10
22秒前
吾皇完成签到 ,获得积分10
23秒前
123发布了新的文献求助30
24秒前
24秒前
顾矜的应助被鲨鱼辣椒采纳,获得10
25秒前
五五完成签到,获得积分10
25秒前
高大的立果完成签到,获得积分10
26秒前
28秒前
佳佳发布了新的文献求助10
29秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192647
求助须知:如何正确求助?哪些是违规求助? 9579118
关于积分的说明 21863752
捐赠科研通 7792215
什么是DOI,文献DOI怎么找? 3436974
关于科研通互助平台的介绍 2560633
邀请新用户注册赠送积分活动 2483864